×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | 3.25 | -4.52 | NA | -18.44 | 0 | |
| PROCTER & GAMBLE HEALTH LIMITE | 3141.0 | 611.8 | 3109.9 | 36.86 | 9,852 | 37.9 |
| ACUTAAS CHEMICALS LIMITED | 2231.75 | 440.11 | 2072.37 | 5.41 | 9555 | 60.2 |
| Jupiter Life Line Hospitals Li | 2,808.65 | 444.47 | 2,739.13 | 6.78 | 9436 | 50.0 |
PROCTER & GAMBLE HEALTH LIMITED, with Security Code 500126, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 310.0 | 320.9 | 301.2 | 304.9 | 310.0 | 252.5 | 283.9 | 313.4 | 309.8 | 311.0 |
| Expenses | 199.6 | 243.4 | 256.0 | 216.3 | 208.3 | 185.0 | 235.6 | 199.4 | 186.3 | 230.1 |
| Operating Profit | 110.4 | 77.5 | 45.2 | 88.7 | 101.7 | 67.4 | 48.3 | 114.0 | 123.4 | 80.9 |
| OPM % | 35.61% | 24.16% | 15.01% | 29.08% | 32.79% | 26.71% | 17% | 36.39% | 39.85% | 26.02% |
| Other Income | 4.5 | 5.0 | 5.5 | 6.1 | 5.2 | 2.3 | -18.1 | 3.3 | 4.0 | 3.1 |
| Interest | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 |
| Depreciation | 9.8 | 3.8 | 6.4 | 6.5 | 6.9 | 6.8 | 7.2 | 5.8 | 5.6 | 5.4 |
| Profit before tax | 104.9 | 78.5 | 44.1 | 88.1 | 99.7 | 62.7 | 43.0 | 111.4 | 121.7 | 78.5 |
| Tax % | -26.8% | -24.6% | -32.4% | -25.5% | -27.7% | -25.8% | 26.5% | 26.1% | -25.3% | 22.1% |
| Net Profit | 76.8 | 59.2 | 29.8 | 65.6 | 72.1 | 46.6 | 16.8 | 82.3 | 90.9 | 61.2 |
| EPS in Rs | 46.3 | 35.7 | 17.96 | 39.5 | 43.4 | 28 | 10.11 | 49.6 | 54.76 | 36.86 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 6% |
| 3 Years: | 5% |
| TTM: | -6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | -24% |
| 3 Years: | 7% |
| TTM: | 8% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 7% |
| 3 Years: | 8% |
| 1 Year: | 14% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|